Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kelch-like family member 1 (KLHL1) is a structural and actin-binding protein encoded by the KLHL1 gene. It belongs to a family of proteins containing BTB/POZ, BACK, and Kelch domains, which facilitate protein-protein interactions and actin cytoskeleton organization within brain cells, particularly neurons[2][7]. KLHL1 is predominantly expressed in the central nervous system and is associated with the regulation of neurite outgrowth and neuronal morphology[2][5]. Its principal biological function is the modulation and organization of the actin cytoskeleton. KLHL1 has also been described as a substrate adaptor within ubiquitin ligase complexes, although its roles in these pathways remain incompletely characterized[2][7]. Variants in KLHL1 are associated with certain neurological disorders such as frontotemporal dementia and spinocerebellar ataxia 8, but it is not recognized as a direct disease driver nor a validated target for pharmacological intervention[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch like family member 1 (KLHL1).